BIOS Health is best understood as a neural-data analytics platform targeting pharma rather than patients, using AI to decode real-time neural signals and correlate them with drug and device efficacy at millisecond resolution. This positions it as infrastructure for precision bioelectronic medicine trials rather than a therapeutic product company, with Series A funding and partnerships across chronic disease indications.